
Tonghua Dongbao Pharmaceutical Co., Ltd.
SSE:600867.SS
8.11 (CNY) • At close June 10, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Tonghua Dongbao Pharmaceutical Co., Ltd. |
Symbool | 600867.SS |
Munteenheid | CNY |
Prijs | 8.09 |
Beurswaarde | 15,534,991,888 |
Dividendpercentage | 2.49% |
52-weken bereik | 7 - 9.64 |
Industrie | Drug Manufacturers—General |
Sector | Healthcare |
CEO | Mr. Sheng Leng Chun |
Website | https://www.thdb.com |
An error occurred while fetching data.
Over Tonghua Dongbao Pharmaceutical Co., Ltd.
Tonghua Dongbao Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells pharmaceutical products for the treatment of diabetes and cardiovascular-based diseases in China. The company operates through Pharmaceutical Industry and Building Materials Industry segments. Its lead product portfolio includes insulin analogues, such as insulin glargine, Insulin aspart, and insulin lispro;
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (CNY)
Cijfers zijn in miljoenen (CNY)